-
Aclarion Announces Pricing of Registered Direct Offering of Common Stock Priced at the Market
January 3, 2025 -
Aclarion Announces Nociscan Featured in RSNA Edition of Siemens MAGNETOM Flash
November 21, 2024 -
Aclarion to Present at the Virtual Investor Summit Microcap Event on November 21st
November 15, 2024
Corporate Overview
Aclarion is a healthcare technology company focused on advancing the care of patients by combining the imaging capabilities of magnetic resonance spectroscopy (MRS) with a proprietary, augmented-intelligence algorithm to noninvasively deliver SaaS solutions that help physicians personalize treatment plans to support improved clinical outcomes and return patients to full, pain-free lives. The company’s first solution will address unmet needs in the low back and neck pain market. To learn more, visit www.aclarion.com.